Merck Reports Favorable Overall Survival Trend for Keytruda Monotherapy
Merck said a favorable overall survival trend was observed for Keytruda monotherapy versus platinum doublet chemotherapy.
Merck said a favorable overall survival trend was observed for Keytruda monotherapy versus platinum doublet chemotherapy.